A phase 1b/2 study to evaluate the safety and efficacy of TTI-101 as monotherapy and in combination in advanced hepatocellular carcinoma Meeting Abstract
| Authors: | Dayyani, F.; Baretti, M.; Lee, S. S.; He, A. R.; Kim, R. D.; Lin, B. S. L.; Enzler, T.; Al Hallak, M. N.; Ulahannan, S. V.; Davis, S. L.; Burgoyne, A.; Tweardy, D.; Harding, J. J.; Kaseb, A. O.; de Achaval, S.; Alibhai, I.; Kauh, J. S. |
| Abstract Title: | A phase 1b/2 study to evaluate the safety and efficacy of TTI-101 as monotherapy and in combination in advanced hepatocellular carcinoma |
| Meeting Title: | 2024 ASCO Gastrointestinal Cancers Symposium |
| Keywords: | 261-566-11347; 261-566-9263; 283-424-425; 227-12145; 298-145-222-184-1022-9124; 3282-270-2820; 298-4770-10048-2376; 38092-33077; 38092-34892 |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-01-20 |
| Language: | English |
| ACCESSION: | WOS:001266680500168 |
| DOI: | 10.1200/JCO.2024.42.3_suppl.TPS577 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS577 -- Source: Wos |
